A Global CRO

10 October 2017

Amarex Clinical Research Joining MC East Asia Business Expansion Trip, October 20-30, 2017

Germantown, MD, USA - Patrick Burke, Sr. Dir. of Business Development, Amarex Clinical Research will be joining the Montgomery County Economic Development Corporation of Maryland on an East Asia Business Expansion Trip to Seoul and Daejeon Metropolitan City in Korea, and Xi’an and Shanghai in China, October 20th-30th, 2017.

Mr. Burke commented, “The objective of this trip is for Amarex to increase our China and Korea client base through meetings with Pharma, Biotech, and medical device company executives. Both countries are active growth areas for Amarex because many Chinese and Korean companies are looking to bring their products to the U.S. market.”

Amarex provides clinical trial contract services designed to assist medical product companies achieve marketing approval for the sale of their new products, or for the sale of approved products into new countries.

About Amarex Clinical Research

Amarex is a global, full service Contract Research Organization (CRO), whose leadership team has significant expertise conducting biomedical research and whose combined experience includes the design and conduct of several hundred clinical research projects in many therapeutic indications. Amarex provides comprehensive services in Project Management (Phase I-IV, BE/BA, PK/PD), Regulatory Affairs, FDA Applications and Submissions, Applications and Submissions to international Health Authorities, GxP Compliance Audits, Clinical Operations, Adaptive Study Designs, Statistical Analysis, Data Management and General Consulting. Amarex has taken clients’ products through the entire approval process from writing the initial product approval strategy to the marketing approval application with a growing list of approved products. Amarex is committed to cost effective, high quality clinical product development.



Contact:
Mirtha Lopez
mirthal@amarexcro.com
20201 Century Blvd, 4th Floor
Germantown, MD 20874
USA
+1-301-528-7000

Back to News